Evidence map›Paper›PMID 38455331›Full record

ArticleFrontiers in epidemiology2022

Olayinka M Olajiga, Alejandro Marin-Lopez, Jenny C Cardenas, Lady Y Gutierrez-Silva, Maria U Gonzales-Pabon, L Paulina Maldonado-Ruiz, Matt Worges, Erol Fikrig, Yoonseong Park, Berlin Londono-Renteria

Open access · diamondAbstract read
In one paragraph

Article in Frontiers in epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Antibodies toFrontiers in immunology · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Olayinka M OlajigaDepartment of Entomology, Kansas State University, Manhattan, KS, United States.
Alejandro Marin-LopezDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Jenny C CardenasLaboratorio Clínico, Hospital Local Los Patios, Los Patios, Colombia.
Lady Y Gutierrez-SilvaLaboratorio Clinico, E.S.E Hospital Emiro Quintero Cañizares, Ocaña, Colombia.
Maria U Gonzales-PabonLaboratorio Clínico, Hospital Erasmo Meoz de Cúcuta, Cúcuta, Colombia.
L Paulina Maldonado-RuizDepartment of Entomology, Kansas State University, Manhattan, KS, United States.
Matt WorgesDepartment of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University of New Orleans, New Orleans, LA, United States.
Erol FikrigDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
Yoonseong ParkDepartment of Entomology, Kansas State University, Manhattan, KS, United States.
Berlin Londono-RenteriaDepartment of Entomology, Kansas State University, Manhattan, KS, United States.
Kansas State University · USYale University · USUniversity of New Orleans · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue fever, caused by the dengue virus (DENV), is currently a threat to about half of the world's population. DENV is mainly transmitted to the vertebrate host through the bite of a female

Indexed as

Ae. aegyptidenguefebrileimmunoglobulin Gpathogenesissalivary proteinsvector borne disease

Identifiers

PMID38455331
PMCPMC10910902
OpenAlexW4308875888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.